Sessions and Coordinators |
|
Gerhard Ecker (U of Vienna, Austria) • Modulation of Multiple Drug Resistance Klaus Bøgesø (Lundbeck, Denmark) • New Trends in Antipsychotic Drug Discovery Toshi Kobayashi (PhRMA, Japan) • Recent Developments in Anticancer Medicine (AFMC Session) Tarek Mansour (Wyeth, USA) • New Antibiotics for Infectious Diseases Gerd Dannhardt (U of Mainz, Germany) • New Approaches in Pain Treatment Chris Kruse (Solvay, The Netherlands) • Screening Technologies in Medicinal Chemistry Giovanni Gaviraghi (Sienabiotech, Italy) • Neurodegeneration: Combining Chemistry and Biology to Harness the Genome Esin Aký Sener and Ýsmail Yalçýn (Ankara U, Turkey) • Computer Assisted Drug Discovery and Optimization Eric De Clercq (Katholieke U Leuven, Belgium) • New Vistas in Antiviral Research William Greenlee (ScheringPlough, USA) • GPCRs I Structure and Ligands Henk Timmerman (Vrije U, The Netherlands) • Teaching and Training in Medicinal Chemistry Edmond Differding (UCB Pharma, Belgium) • Antibodies, Drugs and Tools Kristof Van Emelen (Janssen Res. Found., Belgium) • Epigenetics and Drug Discovery Philip Portoghese (U of Minnesota, USA) • GPCRs II – Molecular Mechanisms John Ellingboe (Wyeth, USA) • In vitro ADME screening technologies in lead identification and optimization Roberto Pellicciari (U of Perugia, Italy) • Adopted Orphan Nuclear Receptors as Therapeutic Targets for Metabolic and Liver Diseases Han van de Waterbeemd (AstraZeneca, UK) • In silico and in combo ADME strategies in drug discovery Trevor Laird (ScientificUpdate, UK) • Process R & D Issues Eric Haaksma (BoehringerIngelheim, Austria) • Membran Proteins and Drug Design Bernd Clement (U of Kiel, Germany) • New Strategies in Prodrug Design (EUFEPS Session) Paul W. Manley (Novartis, Switzerland) • Kinases-Where are we? Serge Halazy (Serono, Switzerland) • Phosphatases-Where to go? Didier Rognan (CNRS, France) • Virtual Screening and Data Mining in Drug Selection Procedures Zhaoyin Wang (Merck Frosst, Canada) • New Cardiovascular Drugs Erden Banoðlu (Gazi U, Turkey) • Revival of Natural Products in Drug Discovery Povl Krogsgaard-Larsen (The Danish U, Denmark) • Ionotropic Neurotransmitter Receptors as Targets for Rational Drug Design Daniel Flynn (Deciphera, USA) • Protein Conformational Plasticity in Drug Discovery (ACS Session-I) • Chemical Genomics (ACS Session-II) Achiel Haemers (U of Antwerp, Belgium) • Tropical Diseases Ferran Sanz (U Pompei Fabra - Spain) • Emerging Issues in Medicinal Chemistry |